104
Views
21
CrossRef citations to date
0
Altmetric
Original Research

HOXA10 deteriorates gastric cancer through activating JAK1/STAT3 signaling pathway

, , , , , & show all
Pages 6625-6635 | Published online: 15 Jul 2019

References

  • Torre LA, Bray F, Siegel RL, Ferlay J. Lortet-Tieulent J and Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi:10.3322/caac.2126225651787
  • Leung CH, Chan DS, Ma VP, Ma DL. DNA-binding small molecules as inhibitors of transcription factors. Med Res Rev. 2013;33:823–846. doi:10.1002/med.2126622549740
  • Zhong Z, Liu LJ, Dong ZQ, et al. Structure-based discovery of an immunomodulatory inhibitor of TLR1-TLR2 heterodimerization from a natural product-like database. Chem Commun (Camb). 2015;51:11178–11181. doi:10.1039/c5cc02728d26051605
  • Liu Y, Zhi X, Yang M, et al. Tumor-triggered drug release from calcium carbonate-encapsulated gold nanostars for near-infrared photodynamic/photothermal combination antitumor therapy. Theranostics. 2017;7:1650–1662. doi:10.7150/thno.1760228529642
  • Noolvi MN, Patel HM, Bhardwaj V, Chauhan A. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent. Eur J Med Chem. 2011;46:2327–2346. doi:10.1016/j.ejmech.2011.03.01521458891
  • Katoh H, Ishikawa S. Genomic pathobiology of gastric carcinoma. Pathol Int. 2017;67:63–71. doi:10.1111/pin.1249328004449
  • Cheng W, Jiang Y, Liu C, Shen O, Tang W, Wang X. Identification of aberrant promoter hypomethylation of HOXA10 in ovarian cancer. J Cancer Res Clin Oncol. 2010;136:1221–1227. doi:10.1007/s00432-010-0772-420151152
  • Shah CA, Wang H, Bei L, Platanias LC, Eklund EA. HoxA10 regulates transcription of the gene encoding transforming growth factor beta2 (TGFbeta2) in myeloid cells. J Biol Chem. 2011;286:3161–3176. doi:10.1074/jbc.M110.18325121087928
  • Yamatoji M, Kasamatsu A, Yamano Y, et al. State of homeobox A10 expression as a putative prognostic marker for oral squamous cell carcinoma. Oncol Rep. 2010;23:61–67.19956865
  • Li B, Jin H, Yu Y, et al. HOXA10 is overexpressed in human ovarian clear cell adenocarcinoma and correlates with poor survival. Int J Gynecol Cancer. 2009;19:1347–1352. doi:10.1111/IGC.0b013e3181a83f1d20009888
  • Li B, Cao X, Weng C, et al. HoxA10 induces proliferation in human prostate carcinoma PC-3 cell line. Cell Biochem Biophys. 2014;70:1363–1368. doi:10.1007/s12013-014-0065-724951955
  • Sentani K, Oue N, Naito Y, et al. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis. Carcinogenesis. 2012;33:1081–1088. doi:10.1093/carcin/bgs12122411957
  • Lim JY, Yoon SO, Seol SY, et al. Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. World J Gastroenterol. 2013;19:7078–7088. doi:10.3748/wjg.v19.i41.707824222951
  • Huang Y, Cen LP, Choy KW, et al. JAK/STAT pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions. Exp Eye Res. 2007;85:684–695. doi:10.1016/j.exer.2007.08.00317869246
  • Spano JP, Milano G, Rixe C, Fagard R. JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications. Eur J Cancer. 2006;42:2668–2670. doi:10.1016/j.ejca.2006.07.00616963263
  • Mullen M, Gonzalez-Perez RR. Leptin-induced JAK/STAT signaling and cancer growth. Vaccines (Basel). 2016;4. doi:10.3390/vaccines4030026
  • Xiao C, Hong H, Yu H, et al. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway. Immunopharmacol Immunotoxicol. 2018;40:278–283. doi:10.1080/08923973.2018.145520829658372
  • Chen L, Lu Z, Yang Y, Du L, Zhou X, Chen Y. Effects of purified omphalia lapidescens protein on metastasis, cell cycle, apoptosis and the JAK-STAT signaling pathway in SGC-7901 human gastric cells. Oncol Lett. 2018;15:4161–4170. doi:10.3892/ol.2018.783029541181
  • Cui XP, Qin CK, Zhang ZH, et al. HOXA10 promotes cell invasion and MMP-3 expression via TGFbeta2-mediated activation of the p38 MAPK pathway in pancreatic cancer cells. Dig Dis Sci. 2014;59:1442–1451. doi:10.1007/s10620-014-3033-624464212
  • Liu J, Jiang Y, Wan Y, Zhou S, Thapa S, Cheng W. MicroRNA665 suppresses the growth and migration of ovarian cancer cells by targeting HOXA10. Mol Med Rep. 2018;18:2661–2668. doi:10.3892/mmr.2018.925230015865
  • Shen ZH, Zhao KM, Du T. HOXA10 promotes nasopharyngeal carcinoma cell proliferation and invasion via inducing the expression of ZIC2. Eur Rev Med Pharmacol Sci. 2017;21:945–952.28338202
  • Guo LM, Ding GF, Xu W, et al. MiR-135a-5p represses proliferation of HNSCC by targeting HOXA10. Cancer Biol Ther. 2018;19:1–28. doi:10.1080/15384047.2018.1450112
  • Zhang L, Wan Y, Jiang Y, et al. Upregulation HOXA10 homeobox gene in endometrial cancer: role in cell cycle regulation. Med Oncol. 2014;31:52. doi:10.1007/s12032-014-0374-024943991
  • Chen Y, Zhang J, Wang H, et al. miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10. BMC Cancer. 2012;12:111. doi:10.1186/1471-2407-12-11122439757
  • Shao L, Chen Z, Peng D, et al. Methylation of the HOXA10 promoter directs miR-196b-5p-dependent cell proliferation and invasion of gastric cancer cells. Mol Cancer Res. 2018;16:696–706. doi:10.1158/1541-7786.MCR-17-065529453320
  • Han Y, Lu S, Wen YG, et al. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer. Eur J Cell Biol. 2015;94:642–652. doi:10.1016/j.ejcb.2015.08.00426552644
  • Liu B, Lu Y, Li J, Liu Y, Liu J, Wang W. Leukemia inhibitory factor promotes tumor growth and metastasis in human osteosarcoma via activating STAT3. Apmis. 2015;123:837–846. doi:10.1111/apm.1242726271643
  • Yeh JE, Frank DA. STAT3-interacting proteins as modulators of transcription factor function: implications to targeted cancer therapy. ChemMedChem. 2016;11:795–801. doi:10.1002/cmdc.20150048226662504
  • Khanna P, Chua PJ, Bay BH, Baeg GH. The JAK/STAT signaling cascade in gastric carcinoma (Review). Int J Oncol. 2015;47:1617–1626. doi:10.3892/ijo.2015.316026398764
  • Yu RX, Hu XM, Xu SQ, Jiang ZJ, Yang W. Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway. Eur J Pharmacol. 2011;657:10–19. doi:10.1016/j.ejphar.2010.12.00621187083
  • Zhang Y, Turkson J, Carter-Su C, et al. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. J Biol Chem. 2000;275:24935–24944. doi:10.1074/jbc.M00238320010823829
  • Liu YC, Lai WC, Chuang KA, et al. Blockade of JAK2 activity suppressed accumulation of beta-catenin in leukemic cells. J Cell Biochem. 2010;111:402–411. doi:10.1002/jcb.2271420503246
  • Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1999;19:1–11. doi:10.1128/mcb.19.1.19858526
  • Park B, Lim JW, Kim H. Lycopene treatment inhibits activation of Jak1/Stat3 and Wnt/beta-catenin signaling and attenuates hyperproliferation in gastric epithelial cells. Nutr Res. 2018. doi:10.1016/j.nutres.2018.07.010
  • Shah CA, Bei L, Wang H, Platanias LC, Eklund EA. HoxA10 protein regulates transcription of gene encoding fibroblast growth factor 2 (FGF2) in myeloid cells. J Biol Chem. 2012;287:18230–18248. doi:10.1074/jbc.M111.32840122493287